AstraZeneca announces first direct-to-patient program offering the brand ARIMIDEX® (anastrozole) Tablets to patients for only $40 per month Patients with a valid prescription would get the ...

AstraZeneca, a pharmaceutical brand, raised awareness of its new drug EVUSHELD – the world's first long-acting monoclonal antibody authorised as a supplement for COVID-19 protection for people who are ...

The program offers the brand ARIMIDEX at the low cost of $40 per month via home delivery,” Davis continued. “It is an important new way for AstraZeneca to help meet U.S. customer needs.” ...